Diabetes Mellitus Type 1 Pathophysiology

Type 1 diabetes occurs as a result of the body's immune system attacking the insulin producing beta cells of the pancreas, although it is not clear why this happens. A lack of insulin in the blood means inadequate amounts of glucose are taken up by cells of the body to provide energy for cellular functions. Consequently, glucose remains in the blood leading to a high blood sugar level. Exactly what causes the immune system to do this is not yet clearly understood but some hypotheses include:

Viral infection - Some research has suggested that the immune system is activated in response to viral infection. As the immune cells are activated against the virus particles, they are also activated against the beta cells of the pancreas. Viruses that have been implicated in the causation of type 1 diabetes include the coxsackie and rubella viruses.

Genetic tendency - Type 1 diabetes seems to run in families which suggests a genetic basis to the pathology of the condition. Some HLA genotypes are known to raise the risk of developing type 1 diabetes.

Development of antibodies - Some researchers have suggested that the development of antibodies against proteins in cow's milk may also lead to the development of antibodies that attack the beta cells of the pancreas. The presence of antibodies against pancreatic beta cells is seen in a subtype of type 1 diabetes mellitus.

There is speculation that lack of vitamin D in the first year of a child's life may raise the risk of type 1 diabetes developing.

Certain drugs and chemicals may also play a role in the development of type 1 diabetes by destroying the pancreatic beta cells. These include chemicals such as pyrinuron (Vacor, N-3-pyridylmethyl-N'-p-nitrophenyl urea) which is used as a rat poison and is no longer used in the USA. An anticancer and antibiotic agent called streptozotocin used to treat pancreatic cancer also destroys the pancreatic beta cells.

Further Reading

Last Updated: Feb 26, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 26). Diabetes Mellitus Type 1 Pathophysiology. News-Medical. Retrieved on August 21, 2019 from https://www.news-medical.net/health/Diabetes-Mellitus-Type-1-Pathophysiology.aspx.

  • MLA

    Mandal, Ananya. "Diabetes Mellitus Type 1 Pathophysiology". News-Medical. 21 August 2019. <https://www.news-medical.net/health/Diabetes-Mellitus-Type-1-Pathophysiology.aspx>.

  • Chicago

    Mandal, Ananya. "Diabetes Mellitus Type 1 Pathophysiology". News-Medical. https://www.news-medical.net/health/Diabetes-Mellitus-Type-1-Pathophysiology.aspx. (accessed August 21, 2019).

  • Harvard

    Mandal, Ananya. 2019. Diabetes Mellitus Type 1 Pathophysiology. News-Medical, viewed 21 August 2019, https://www.news-medical.net/health/Diabetes-Mellitus-Type-1-Pathophysiology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
New circulating immune cell could help predict type 1 diabetes risk